Skip to content
Screener

Xencor XNCR Common Stock

Common Stock at other companies

Amgen logo
AmgenAMGN
2.8B0.0%
Janux Therapeutics logo
Janux TherapeuticsJANX
$61K+3.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$821.24M+3.7%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$29K-3.3%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
200M0.0%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$2.43B+65.2%

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.6B+221%
Enterprise value$1.73B+159%
P/S15.3×+11.9×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemJune 30,2026December 31,2025
Total liabilities221,732239,908
Commitments and contingencies
Noncontrolling interest and stockholders’ equity
Common stock, $0.01 par value: Authorized 200,000 sharesIssued and outstanding 74,329 and 71,872 shares at June 30, 2026 and December 31, 2025, respectively.744718
Additional paid-in capital1,449,9601,429,252
Accumulated other comprehensive (loss) income(872)1,576
Accumulated deficit(946,604)(795,959)
Total stockholders’ equity attributable to Xencor, Inc.503,228635,587

Item 1. Financial Statements

FAQ

What is Xencor's common stock?
Xencor (XNCR) reported common stock of $744K in Q2 2026.
How has Xencor's common stock changed year-over-year?
Xencor's common stock increased by 4.2% year-over-year, from $714K to $744K.
What is the long-term trend for Xencor's common stock?
Over 5 years (2020 to 2025), Xencor's common stock has grown at a 4.4% compound annual growth rate (CAGR), from $580K to $718K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Xencor's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude